186 related articles for article (PubMed ID: 6366804)
21. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
[TBL] [Abstract][Full Text] [Related]
22. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
23. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
Frick MH; Hartikainen M; Pörsti P
Ann Clin Res; 1978 Apr; 10(2):105-6. PubMed ID: 28071
[TBL] [Abstract][Full Text] [Related]
24. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
[TBL] [Abstract][Full Text] [Related]
25. [Penbutolol and arterial hypertension].
Torriani A; Bravi M; Broglia M; Giuffrè G; Carisdeo V
Minerva Med; 1987 Sep; 78(18):1375-80. PubMed ID: 3658210
[TBL] [Abstract][Full Text] [Related]
26. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
27. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
Sjöberg KH
Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
[TBL] [Abstract][Full Text] [Related]
28. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
[TBL] [Abstract][Full Text] [Related]
29. [Validity of the use of penbutolol in essential arterial hypertension].
Pepe S; Scalici G; D'Angelo A; Curiale B; Corrao S; Agnello C
Minerva Med; 1990 Jun; 81(6):471-3. PubMed ID: 2359502
[TBL] [Abstract][Full Text] [Related]
30. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements.
De Plaen JF; Vander Elst E; Van Ypersele de Strihou C
Br J Clin Pharmacol; 1981 Aug; 12(2):215-21. PubMed ID: 7030372
[TBL] [Abstract][Full Text] [Related]
31. Propranolol-hydrochlorothiazide combination in essential hypertension.
Stevens JD; Mullane JF
Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
[TBL] [Abstract][Full Text] [Related]
32. Long-acting beta-blockers in the twenty-fourth hour. A comparison in hypertension.
Hackett GI; Harrison P; Kershaw S
Practitioner; 1981 May; 225(1355):752-5. PubMed ID: 7027230
[No Abstract] [Full Text] [Related]
33. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
[TBL] [Abstract][Full Text] [Related]
34. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive efficacy of propranolol given twice daily.
MacLeod SM; Hamet P; Kaplan H; Larochelle P; Nadeau J; Ogilvie RI; Rangno RE; Ruedy J; Sellers EM; Ti TY
Can Med Assoc J; 1979 Sep; 121(6):737-40. PubMed ID: 391380
[TBL] [Abstract][Full Text] [Related]
36. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
Parry EE; Arr S; Tait D
Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group.
Schoenberger JA
Am J Cardiol; 1989 Jun; 63(18):1339-42. PubMed ID: 2658525
[TBL] [Abstract][Full Text] [Related]
38. Metoprolol for hypertension. Open trial in general practice.
Fredman RM
Med J Aust; 1982 Oct; 2(8):378-80. PubMed ID: 6755204
[TBL] [Abstract][Full Text] [Related]
39. Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans.
Venter CP; Joubert PH; Venter HL; Muntingh GL; du Plooy WJ
J Clin Pharmacol; 1990 Jun; 30(6):533-7. PubMed ID: 2355104
[TBL] [Abstract][Full Text] [Related]
40. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
